The Iowa Ethics and Campaign Disclosure Board has voted unanimously to open a formal investigation into a complaint involving campaign spending by Republican State Representative Jeff Shipley of Birmingham.
The investigation, designated Case 26-FC-1315, centers on $15,270 in payments made by Shipley’s campaign committee, the Committee for Peace and Prosperity, to the Health Research Institute in Fairfield for a study examining pesticide exposure among Iowans.
The board’s order, issued November 12th, found the complaint sufficient to move forward on two legal theories. The first questions whether the payments violated Iowa Code 68A.303, which prohibits attaching conditions to campaign funds transferred to a charitable organization. The second questions whether the payments violated Iowa Code 68A.302, which prohibits using campaign funds for personal benefit.
The board noted that Shipley has publicly described himself as the study’s lead author and primary financier, raising what it called a legitimate question about whether he directly benefited from the transfers. The board also noted that the funds appeared to have been designated for a specific study.
Board staff noted that transferring campaign funds to a 501(c)(3) organization is permissible under Iowa law — the question is whether the funds were earmarked for a specific purpose, which would not be allowed. Staff also said it remains unclear whether Shipley’s relationship with the Health Research Institute created any personal financial benefit.
The two payments — $3,270 in March and $12,000 in April — were recorded in campaign finance filings as charitable contributions. The committee’s website had directed donors to a research page, telling them all contributions would go toward the pesticide study at the Health Research Institute.
Board staff are directed to investigate whether probable cause exists to establish a violation and may issue subpoenas for testimony and records. Opening an investigation is not a finding of wrongdoing, and no violation of Iowa campaign finance law has been established.
Shipley issued a statement defending the expenditures.
“This past year, I’ve been collaborating with Dr. John Fagan and the Health Research Institute (HRI) in Fairfield to generate baseline data of pesticide exposure among typical Iowans,” Shipley said. “This project is on the cutting edge of scientific research, the team at HRI is literally pioneering new methods and techniques to perform this analysis. I expect to submit our findings for publication in the months ahead. It’s an honor to be involved in this project and to explore this scientific frontier for the benefit of the public.”
“The complaint against me is totally frivolous and is a result of some random idiot using AI tools to harass public servants,” he said. “The complaint alleges my campaign’s partnership with Dr. John Fagan and HRI is somehow a direct financial benefit to me. Because I have not benefited financially, I expect this matter to be resolved quickly.”
“Our campaign’s investment of over $25,000 to generate this data on pesticide exposure is completely authorized under Iowa code,” Shipley continued, “as this expenditure not only enhanced my candidacy but also represents a genuine public service to constituents. For the last three legislative sessions, we have debated bills on pesticide regulations and liability protections, so this expenditure and generating this data is also a bona fide duty of holding elected office.”
“The reality is that our Pesticide Research Project is perhaps the greatest campaign expenditure ever devised by a candidate for public office in Iowa,” he added. “Iowans are much better served by direct investments in scientists like Dr. John Fagan and his team to collect and analyze samples for pesticides than they are with endless streams of distorted political advertising on television and mailboxes.”
“The complainant should be ashamed and ridiculed for asserting such baseless allegations against an investment of such profound significance and benefit to the public,” Shipley said.















